These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16454584)

  • 1. [Degree of fulfillment of the objectives of metabolic control and cardiovascular risk factors in patients with type 2 diabetes in an area of primary attention].
    González Sarmiento E; Vielba Dueñas B; Fernández Galante I; Manso García S; San Pedro Martín Y; Vielba Dueñas D; Fernández González R
    An Med Interna; 2005 Nov; 22(11):520-4. PubMed ID: 16454584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].
    Rodríguez Bernardino A; García Polavieja P; Reviriego Fernández J; Serrano Ríos M
    Endocrinol Nutr; 2010 Feb; 57(2):60-70. PubMed ID: 20153706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of control of cardiovascular risk factors in type 2 diabetic population of Ciudad Real province].
    Grupo ELIPSE
    Rev Clin Esp; 2005 May; 205(5):218-22. PubMed ID: 15970152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of metabolic syndrome estimated with the new World Health Organization recommendations. The HERMEX study].
    Fernández-Bergés D; Félix-Redondo FJ; Lozano L; Pérez-Castán JF; Sanz H; Cabrera De León A; Hidalgo AB; Morcillo Y; Tejero V; Alvarez-Palacios P
    Gac Sanit; 2011; 25(6):519-24. PubMed ID: 21803460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain.
    Orozco-Beltrán D; Gil-Guillen VF; Quirce F; Navarro-Perez J; Pineda M; Gomez-de-la-Cámara A; Pita S; Diez-Espino J; Mateos J; Merino J; Serrano-Rios M;
    Int J Clin Pract; 2007 Jun; 61(6):909-15. PubMed ID: 17504353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence survey of cardiovascular risk factors in the general population in St. Louis (Senegal)].
    Pessinaba S; Mbaye A; Yabéta GA; Harouna H; Sib AE; Kane AD; Bodian M; Ndiaye MB; Mbaye-Ndour M; Niang K; Diagne-Sow D; Diack B; Kane M; Diao M; Mathieu JB; Kane A
    Ann Cardiol Angeiol (Paris); 2013 Aug; 62(4):253-8. PubMed ID: 23540763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya.
    Kimando MW; Otieno FCF; Ogola EN; Mutai K
    BMC Endocr Disord; 2017 Dec; 17(1):73. PubMed ID: 29191193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].
    Reindel J; Zander E; Heinke P; Kohnert KD; Allwardt C; Kerner W
    Herz; 2004 Aug; 29(5):463-9. PubMed ID: 15340731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes, a public health problem. The epidemiology of sugar diabetes and its long term complications].
    Ekoé JM; Emond V; Huot C
    Perspect Infirm; 2006; 4(2):10-6. PubMed ID: 17184091
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges in preventing cardiovascular complications in type 2 diabetes in primary care.
    Ubink-Veltmaat LJ; Bilo HJ; Groenier KH; Rischen RO; Meyboom-de Jong B
    Eur J Gen Pract; 2005 Mar; 11(1):11-6. PubMed ID: 15841058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of vascular disease in premenopausal women with diabetes mellitus.
    García NH; Pérez HA; Spence JD; Armando LJ
    Clin Ther; 2014 Dec; 36(12):1924-1934. PubMed ID: 24998421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: a population based analysis from a Scottish region.
    Collier A; Ghosh S; Hair M; Waugh N
    Diabetes Metab; 2015 Apr; 41(2):145-51. PubMed ID: 25454092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study.
    Valdivielso P; Sánchez-Chaparro MA; Calvo-Bonacho E; Cabrera-Sierra M; Sainz-Gutiérrez JC; Fernández-Labandera C; Fernández-Meseguer A; Quevedo-Aguado L; Moraga MR; Gálvez-Moraleda A; González-Quintela A; Roman-Garcia J;
    Atherosclerosis; 2009 Dec; 207(2):573-8. PubMed ID: 19545869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level at which control objectives are reached in patients in different population groups with type 2 diabetes].
    Herrero A; Pinillos J; Sabio P; Martín JL; Garzón G; Gil Á
    Semergen; 2017; 43(8):550-556. PubMed ID: 27889132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of patients with type 2 diabetes of short duration in Poland: Rationale, design and preliminary results of the ARETAEUS1 study.
    Bała MM; Płaczkiewicz-Jankowska E; Topór-Madry R; Leśniak W; Wiercińska E; Szczepaniak P; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Pol Arch Med Wewn; 2009 Sep; 119(9):533-40. PubMed ID: 19776697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integral control of cardiovascular risk factors in type 2 diabetes in the Pallars Jussà and Sobirà regions (area of influence of the regional hospital of Pallars-Lleida)].
    Porres LD; Solans MR; Oña MF; Morilla L; Isarn RM; Milian ES; Pujol LE
    Rev Clin Esp; 2010; 210(7):332-7. PubMed ID: 20510408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of cardiovascular risk factors in type 2 diabetes in a specialized diabetic clinic].
    Pérez-Pevida B; Varela N; Pérez Rodríguez S; Martínez Segura E; Salvador J; Escalada J
    An Sist Sanit Navar; 2017 Dec; 40(3):413-420. PubMed ID: 29215656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.